Oak Thistle LLC Takes $3.46 Million Position in Agilent Technologies, Inc. $A

Oak Thistle LLC purchased a new stake in shares of Agilent Technologies, Inc. (NYSE:A) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 25,409 shares of the medical research company’s stock, valued at approximately $3,457,000. Agilent Technologies accounts for about 0.5% of Oak Thistle LLC’s portfolio, making the stock its 18th biggest holding.

Other large investors have also made changes to their positions in the company. AQR Capital Management LLC raised its position in shares of Agilent Technologies by 424.1% during the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after purchasing an additional 1,652,244 shares during the period. Ameriprise Financial Inc. raised its position in shares of Agilent Technologies by 132.2% during the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after purchasing an additional 1,340,161 shares during the period. Troy Asset Management Ltd raised its position in shares of Agilent Technologies by 74.3% during the second quarter. Troy Asset Management Ltd now owns 2,397,820 shares of the medical research company’s stock worth $282,967,000 after purchasing an additional 1,021,865 shares during the period. Ilex Capital Partners UK LLP acquired a new stake in shares of Agilent Technologies during the second quarter worth about $96,684,000. Finally, SG Americas Securities LLC raised its position in shares of Agilent Technologies by 3,091.1% during the fourth quarter. SG Americas Securities LLC now owns 808,215 shares of the medical research company’s stock worth $109,974,000 after purchasing an additional 782,888 shares during the period. Institutional investors and hedge funds own 87.41% of the company’s stock.

Agilent Technologies Stock Down 0.9%

NYSE:A opened at $113.78 on Wednesday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. The company has a market cap of $32.15 billion, a PE ratio of 25.12, a PEG ratio of 2.43 and a beta of 1.30. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $160.27. The stock has a 50-day simple moving average of $120.42 and a 200 day simple moving average of $134.37.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). The firm had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The firm’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, sell-side analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be paid a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.52%.

Analyst Ratings Changes

A has been the topic of a number of research analyst reports. Barclays dropped their price target on Agilent Technologies from $165.00 to $150.00 and set an “overweight” rating on the stock in a research report on Thursday, February 26th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Agilent Technologies in a research report on Monday, December 29th. Evercore raised Agilent Technologies from an “in-line” rating to an “outperform” rating and raised their price target for the stock from $155.00 to $160.00 in a research report on Monday, January 5th. Wells Fargo & Company dropped their price target on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research report on Thursday, February 26th. Finally, UBS Group dropped their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Two research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $161.20.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.